Status:
COMPLETED
Protein Expression in Human Neuroblastoma Tumor Samples
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Neuroblastoma
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying protein expression in samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers relate...
Detailed Description
OBJECTIVES: * To determine whether intersectin (ITSN1) proteins are present at elevated levels in primary human tumor samples. OUTLINE: Archived tumor tissue samples are analyzed for intersectin (IT...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosed with neuroblastoma
- Banked primary tumor samples from patients with stage 1, 2, 3, and 4 disease
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01407731
Start Date
July 1 2011
End Date
May 1 2016
Last Update
May 17 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.